This Is Why Amgen's New Cancer Drug Could Be Huge [The Motley Fool]
Mirati Therapeutics, Inc. (MRTX)
Last mirati therapeutics, inc. earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mirati.com/node/5806
Company Research
Source: The Motley Fool
Cory Renauer(TMFangapples)Author BioCory is a long-term minded analyst focused on the Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.Follow @coryrenauerBiotechnology stocks are famous for dramatic price movements butsmart investorsNASDAQ:AMGNDespite its size, Amgen can move quickly where it matters most. On May 8, 0, the FDA granted a highly accelerated approval to a new lung cancer therapy in record time. This is why Lumakras could allow this biotech stock to deliver oversized gains for at least another decade.Image source: Getty Images.A long time coming?Scientists have known that mutant KRAS proteins were responsible for aggressive tumor growth for decades, but they aren't easy to manipulate. Once Amgen realized Lumakras could tackle aggressive cancer cases the company turbocharged its development.Amgen announced the first human proof-of-concept data for Lumakrasin 09Lumakras is the first KRAS inhibitor to earn approval
Show less
Read more
Impact Snapshot
Event Time:
MRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRTX alerts
High impacting Mirati Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics